Literature DB >> 1032901

2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect.

J Michl, D J Ohlbaum, S C Silverstein.   

Abstract

Incubation of normal or thioglycollate-elicited mouse peritoneal macrophages with 2-deoxy-D-glucose (2-dG) inhibits the capacity of these macrophages to phagocytize IgG- or complement-coated particles via their Fc and C3 receptors. 2-dG has no inhibitory effect on the capacity of these macrophages to phagocytize latex or zymosan particles, which are ingested in the absence of specific opsonins, and it does not inhibit binding of IgG- or C3-coated particles to their respective receptors on the macrophage's plasma membrane. 2-dG exerts its inhibitory effect on the macrophage and not on the opsonized particle. The inhibition is independent of particle size, occurs within 15-30 min of addition of this glucose analogue to the medium at 37 degrees C, cannot be overcome by supra-agglutinating amounts of opsonizing antibody, and is completely reversible by substitution of 5.5 mM glucose for 50 mM 2-dG in the medium. Addition of equimolar amounts of glucose or mannose, but not of fructose, galactose, fucose, or glucosamine, to medium containing 50 mM 2-dG results in substantial reversal of the inhibitory effect of 2-dG on Fc and C3 receptor mediated phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1032901      PMCID: PMC2190494          DOI: 10.1084/jem.144.6.1465

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Purine and pyrimidine transport by cultured Novikoff cells. Specificities and mechanism of transport and relationship to phosphoribosylation.

Authors:  J M Zylka; P G Plagemann
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

2.  Attachment of modified erythrocytes to phagocytic cells in absence of serum.

Authors:  M Rabinovitch
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

3.  Nucleoside-diphosphate derivatives of 2-deoxy-D-glucose in animal cells.

Authors:  M F Schmidt; R T Schwarz; C Scholtissek
Journal:  Eur J Biochem       Date:  1974-11-01

4.  Impaired leukocyte function in patients with poorly controlled diabetes.

Authors:  J D Bagdade; R K Root; R J Bulger
Journal:  Diabetes       Date:  1974-01       Impact factor: 9.461

5.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

6.  The selective inhibition of macrophage phagocytic receptors by anti-membrane antibodies.

Authors:  P Holland; N H Holland; Z A Cohn
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

7.  Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG).

Authors:  B Mantovani; M Rabinovitch; V Nussenzweig
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

8.  Segmental response of the macrophage plasma membrane to a phagocytic stimulus.

Authors:  F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

9.  Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes.

Authors:  F M Griffin; J A Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

10.  Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate.

Authors:  J G Hirsch; M E Fedorko
Journal:  J Cell Biol       Date:  1968-09       Impact factor: 10.539

View more
  59 in total

Review 1.  A guide to immunometabolism for immunologists.

Authors:  Luke A J O'Neill; Rigel J Kishton; Jeff Rathmell
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

2.  Comparative studies of endotoxin uptake by isolated rat Kupffer and peritoneal cells.

Authors:  E S Fox; P Thomas; S A Broitman
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Phagocytosis of latex microspheres by bovine meshwork cells in culture.

Authors:  I Grierson; J Day; W G Unger; A Ahmed
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; I Dubbeldeman-Rempt; R van Furth
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

5.  Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.

Authors:  T S Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

6.  Induction by dimethyl sulfoxide of Fc fragment-mediated phagocytosis in the mouse macrophage-like cell line P388D1.

Authors:  S Takasaki; L Leive
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages.

Authors:  R J Bonney; P D Wightman; P Davies; S J Sadowski; F A Kuehl; J L Humes
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

8.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; M R Daha; R van Furth
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

9.  Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose.

Authors:  D P Speert; S Gordon
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.